US drug approvals
1 approvals with a product on the US market
- Vpriv BLA022575 · approved 26 Feb 2010
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- See reportsGrowth in full reports
Free public data on Shire Human Genetic
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on openFDA (opens in a new tab)
Markets where public records show them
Markets we cover where free public records show Shire Human Genetic: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Shire Human Genetic is in.
From our blog
Stories on the topics Shire Human Genetic works in.
Patient Support Programmes: Helping Patients Stay on Treatment
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Biologic Safety Testing: The Quiet Backbone of Drug Making
Every vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches…
Read
Cell-Based Immunotherapy: Promise and Price
The first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
Read